MedTrace Logo

Randomized Controlled Trial of Routine Screening for IPV

NCT00526994 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 2700

Last updated 2013-07-31

Study results available
· View outcomes & findings →

Summary

This is a randomized controlled trial with three arms to establish the impact of screening and referral to services for women disclosing exposure to IPV.

Conditions

  • Quality of Life
  • Disability
  • Utilization of Health Care Services

Interventions

OTHER

screened

Asked 4 questions on current exposure to intimate partner violence; if positive, receives referral information

BEHAVIORAL

universal education

receives referral information

Sponsors & Collaborators

Principal Investigators

  • Joanne Klevens, MD, PhD · Centers for Disease Control and Prevention

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-05-31
Primary Completion
2011-06-30
Completion
2011-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00526994 on ClinicalTrials.gov